Search results for "Repressor"

showing 10 items of 212 documents

Cyclic AMP-inducible genes respond uniformly to seasonal lighting conditions in the rat pineal gland

2006

The encoding of photoperiodic information ensues in terms of the daily profile in the expression of cyclic AMP (cAMP)-inducible genes such as the arylalkylamine N-acetyltransferase (AA-NAT) gene that encodes the rate-limiting enzyme in melatonin formation. In the present study, we compared the influence of the photoperiodic history on the cAMP-inducible genes AA-NAT, inducible cyclic AMP early repressor (ICER), fos-related antigen-2 (FRA-2), mitogen-activated protein kinase phosphatase-1 (MKP-1), nerve growth factor inducible gene-A (NGFI-A) and nerve growth factor inducible gene-B (NGFI-B) in the pineal gland of rats. For this purpose, we monitored the daily profiles of each gene in the sa…

Maleendocrine systemmedicine.medical_specialtyLightRepressorBiologyPineal GlandCyclic AMP Response Element ModulatorRats Sprague-DawleyPineal glandInternal medicineCyclic AMPmedicineAnimalsRNA MessengerCircadian rhythmProtein kinase AphotoperiodismReverse Transcriptase Polymerase Chain ReactionGeneral NeuroscienceCircadian RhythmRatsEndocrinologyNerve growth factormedicine.anatomical_structureGene Expression RegulationArylalkylamineFemalehormones hormone substitutes and hormone antagonistsEndocrine glandNeuroscience
researchProduct

TORC1 Inhibition by Rapamycin Promotes Antioxidant Defences in a Drosophila Model of Friedreich’s Ataxia

2015

Friedreich's ataxia (FRDA), the most common inherited ataxia in the Caucasian population, is a multisystemic disease caused by a significant decrease in the frataxin level. To identify genes capable of modifying the severity of the symptoms of frataxin depletion, we performed a candidate genetic screen in a Drosophila RNAi-based model of FRDA. We found that genetic reduction in TOR Complex 1 (TORC1) signalling improves the impaired motor performance phenotype of FRDA model flies. Pharmacologic inhibition of TORC1 signalling by rapamycin also restored this phenotype and increased the lifespan and ATP levels. Furthermore, rapamycin reduced the altered levels of malondialdehyde + 4-hydroxyalke…

Malelcsh:MedicineGene Expressionmedicine.disease_causeAntioxidantsAnimals Genetically ModifiedAdenosine Triphosphate0302 clinical medicineRNA interferenceIron-Binding ProteinsMalondialdehydeDrosophila Proteinslcsh:ScienceAconitate HydrataseGenetics0303 health sciencesMultidisciplinaryReverse Transcriptase Polymerase Chain ReactionGlutathione3. Good healthCell biologyDrosophila melanogasterRNA Interferencemedicine.symptomImmunosuppressive AgentsDrosophila ProteinResearch ArticleAtaxiaLongevityMotor ActivityBiologyAconitase03 medical and health sciencesmedicineAnimalsHumans030304 developmental biologySirolimusAldehydesSuperoxide Dismutaselcsh:RAutophagyRepressor ProteinsDisease Models AnimalOxidative StressFriedreich AtaxiaFrataxinbiology.proteinlcsh:Q030217 neurology & neurosurgeryOxidative stressTranscription FactorsGenetic screenPLOS ONE
researchProduct

Clinical spectrum of eye malformations in four patients with Mowat-Wilson syndrome

2015

Mowat-Wilson syndrome (MWS) is a rare genetic syndrome characterized by a specific facial gestalt, intellectual deficiency, Hirschsprung disease and multiple congenital anomalies. Heterozygous mutations or deletions in the zinc finger E-box-binding homeobox2 gene (ZEB2) cause MWS. ZEB2 encodes for Smad-interacting protein 1, a transcriptional co-repressor involved in TGF-beta and BMP pathways and is strongly expressed in early stages of development in mice. Eye abnormalities have rarely been described in patients with this syndrome. Herein, we describe four patients (two males and two females; mean age 7 years) with MWS and eye malformations. Ocular anomalies included, iris/retinal coloboma…

Malemedicine.medical_specialtyAdolescentgenetic structuresMowat–Wilson syndromeRetinal Pigment EpitheliumBiologyEyeCataractchemistry.chemical_compoundAtrophyIntellectual DisabilityOphthalmologyGeneticsmedicineHumansHirschsprung Disease[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansIris (anatomy)HyphemaGenetics (clinical)Zinc Finger E-box Binding Homeobox 2Homeodomain ProteinsRetinaFaciesOptic NerveRetinalAnatomymedicine.diseaseeye diseasesColobomaRepressor Proteinsmedicine.anatomical_structurechemistryChild PreschoolLens (anatomy)MutationMicrocephalyOptic nerveFemalesense organsAtrophy[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyAmerican Journal of Medical Genetics Part A
researchProduct

Differential expression of suppressors of cytokine signaling-1, -2, and -3 in the rat hippocampus after seizure: implications for neuromodulation by …

2003

Numerous studies have investigated the expression of various cytokine families in the CNS after brain injury. The gp130 or interleukin (IL)-6-type cytokines have received a great deal of focus, and it is clear that they exhibit an acute and robust upregulation in various brain injury models. We are interested to determine, however, whether endogenously expressed cytokines in the CNS act in a direct neuromodulatory manner. In an accompanying study, we examined the expression of five gp130 cytokines and their receptors in the lithium-pilocarpine model of status epilepticus. We follow up that study here by trying to determine if gp130 signal transduction occurs in hippocampal principal neurons…

Malemedicine.medical_treatmentPopulationSuppressor of Cytokine Signaling ProteinsHippocampal formationBiologyNeuroprotectionHippocampusRats Sprague-DawleySuppressor of Cytokine Signaling 1 ProteinSeizuresmedicineAnimalsRNA MessengerReceptors Cytokineeducationeducation.field_of_studyGeneral NeuroscienceInterleukinGlycoprotein 130RatsDNA-Binding ProteinsRepressor ProteinsCytokineGene Expression RegulationSuppressor of Cytokine Signaling 3 ProteinTrans-ActivatorsCytokinesSignal transductionCytokine receptorCarrier ProteinsNeuroscienceSignal TransductionTranscription FactorsNeuroscience
researchProduct

2019

The Gram-positive soil bacterium Bacillus subtilis relies on the glutamine synthetase and the glutamate synthase for glutamate biosynthesis from ammonium and 2-oxoglutarate. During growth with the carbon source glucose, the LysR-type transcriptional regulator GltC activates the expression of the gltAB glutamate synthase genes. With excess of intracellular glutamate, the gltAB genes are not transcribed because the glutamate-degrading glutamate dehydrogenases (GDHs) inhibit GltC. Previous in vitro studies revealed that 2-oxoglutarate and glutamate stimulate the activator and repressor function, respectively, of GltC. Here, we have isolated GltC variants with enhanced activator or repressor fu…

Microbiology (medical)0303 health sciencesbiology030306 microbiologyActivator (genetics)ChemistryGlutamate dehydrogenaseWild typeRepressorPromoterBacillus subtilisbiology.organism_classificationMicrobiology03 medical and health sciencesBiochemistryGlutamate synthaseGlutamine synthetasebiology.protein030304 developmental biologyFrontiers in Microbiology
researchProduct

Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis.

2004

The transcription factor c-Jun cooperates with oncogenic alleles of ras in malignant transformation. Constitutively active Ras causes, via activation of mitogen activated protein kinases, phosphorylation of c-Jun which is essential for subsequent target gene activation and tumorigenesis. Studying the mechanisms controlling c-Jun activity we found that its transcription activation function is actively repressed by a presumably multimeric repressor complex that includes histone deacetylase 3 as a critical subunit. Suppression of c-Jun is relieved by MAP kinase-mediated phosphorylation and/or titration of inhibitor components. The viral tumorigenic counterpart of c-Jun, v-Jun, escapes this inh…

Mitogen-Activated Protein Kinase KinasesTranscriptional ActivationKinaseProtein subunitc-junCell CycleRepressorCell BiologyBiologyHDAC3Histone DeacetylasesMalignant transformationEnzyme ActivationRepressor ProteinsCell Transformation NeoplasticGenes junCancer researchras ProteinsPhosphorylationAnimalsHumansPhosphorylationMolecular BiologyTranscription factorDevelopmental Biology
researchProduct

All-atom simulations disentangle the functional dynamics underlying gene maturation in the intron lariat spliceosome

2018

The spliceosome (SPL) is a majestic macromolecular machinery composed of five small nuclear RNAs and hundreds of proteins. SPL removes noncoding introns from precursor messenger RNAs (pre-mRNAs) and ligates coding exons, giving rise to functional mRNAs. Building on the first SPL structure solved at near–atomic-level resolution, here we elucidate the functional dynamics of the intron lariat spliceosome (ILS) complex through multi-microsecond-long molecular-dynamics simulations of ∼1,000,000 atoms models. The ILS essential dynamics unveils (i) the leading role of the Spp42 protein, which heads the gene maturation by tuning the motions of distinct SPL components, and (ii) the critical particip…

Models Molecular0301 basic medicineProtein ConformationSplicingExonMolecular dynamicsRNA; gene maturation; molecular dynamics; spliceosome; splicingModelsRNA Small NuclearRNA PrecursorsMagnesiumPrincipal Component AnalysisMultidisciplinaryChemistrySpliceosomeFungalPhysical SciencesRNA splicingSpliceosomeRNA Splicing1.1 Normal biological development and functioningStatic ElectricityComputational biologyMolecular dynamicsMolecular Dynamics Simulation03 medical and health sciencesMotionsplicingU5 Small NuclearSmall NuclearGeneticUnderpinning researchSchizosaccharomycesGeneticsComputer SimulationGeneRibonucleoprotein U5 Small NuclearModels Geneticgene maturationIntronRNAMolecularRNA FungalRibonucleoproteinIntronsmolecular dynamicsRepressor Proteins030104 developmental biologyGene maturationHelixSpliceosomesRNANucleic Acid ConformationSchizosaccharomyces pombe ProteinsGeneric health relevancespliceosome
researchProduct

Recurrent Mutations in the Basic Domain of TWIST2 Cause Ablepharon Macrostomia and Barber-Say Syndromes

2015

Contains fulltext : 153827.pdf (Publisher’s version ) (Open Access) Ablepharon macrostomia syndrome (AMS) and Barber-Say syndrome (BSS) are rare congenital ectodermal dysplasias characterized by similar clinical features. To establish the genetic basis of AMS and BSS, we performed extensive clinical phenotyping, whole exome and candidate gene sequencing, and functional validations. We identified a recurrent de novo mutation in TWIST2 in seven independent AMS-affected families, as well as another recurrent de novo mutation affecting the same amino acid in ten independent BSS-affected families. Moreover, a genotype-phenotype correlation was observed, because the two syndromes differed based s…

Models MolecularCandidate geneHirsutismProtein ConformationHeLa Cellmedicine.disease_causeTranscriptomeTwist transcription factorModelsGenetics(clinical)ExomeEye AbnormalitiesNon-U.S. Gov'tExomeGenetics (clinical)ZebrafishGeneticsMutationMicroscopyMacrostomiaSetleis syndromeHypertelorismResearch Support Non-U.S. Gov'tHypertrichosiEyelid DiseaseGENÉTICAPhenotypeEyelid DiseasesAbnormalitiesMultipleSequence AnalysisHumanChromatin ImmunoprecipitationMolecular Sequence DataMutation MissenseHypertrichosisAbnormalities; Multiple; Amino Acid Sequence; Animals; Base Sequence; Chromatin Immunoprecipitation; Exome; Eye Abnormalities; Eyelid Diseases; HeLa Cells; Hirsutism; Humans; Hypertelorism; Hypertrichosis; Macrostomia; Microscopy; Electron; Molecular Sequence Data; Mutation; Missense; Protein Conformation; Repressor Proteins; Sequence Analysis; DNA; Skin Abnormalities; Twist Transcription Factor; Zebrafish; Models; Molecular; Phenotype; Genetics; Genetics (clinical)Other Research Radboud Institute for Molecular Life Sciences [Radboudumc 0]BiologyResearch SupportElectronArticleFrameshift mutationGeneticAblepharon macrostomia syndromeSkin AbnormalitieGeneticsmedicineJournal ArticleAnimalsHumansAbnormalities MultipleAmino Acid SequenceNeurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7]Base SequenceAnimalTwist-Related Protein 1MolecularSequence Analysis DNADNARepressor Proteinmedicine.diseaseRepressor ProteinsTwist Transcription FactorEye AbnormalitieMicroscopy ElectronMutationSkin Abnormalitiessense organsMissenseNanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19]HeLa CellsAmerican journal of human genetics
researchProduct

Site-specific Labelling with a Metal Chelator for Protein-structure Refinement

2004

A single free Cys sidechain in the N-terminal domain of the E. coli arginine repressor was covalently derivatized with S-cysteaminyl-EDTA for site-specific attachment of paramagnetic metal ions. The effects of chelated metal ions were monitored with (15)N-HSQC spectra. Complexation of Co(2+), which has a fast relaxing electron spin, resulted in significant pseudocontact shifts, but also in peak doubling which was attributed to the possibility of forming two different stereoisomers of the EDTA-Co(2+) complex. In contrast, complexation of Cu(2+) or Mn(2+), which have slowly relaxing electron spins, did not produce chemical shift changes and yielded self-consistent sets of paramagnetic relaxat…

Models MolecularMagnetic Resonance SpectroscopyTime FactorsMetal ions in aqueous solutionElectronsGadoliniumBiochemistryIonParamagnetismchemistry.chemical_compoundNuclear magnetic resonanceBacterial ProteinsAmideEscherichia coliChelationCysteineEdetic AcidSpectroscopyChelating AgentsIonsManganeseElectronic correlationChemistryRelaxation (NMR)Electron Spin Resonance SpectroscopyProteinsCobaltDNAProtein Structure TertiaryRepressor ProteinsCrystallographyModels ChemicalCovalent bondProtonsCopperJournal of Biomolecular NMR
researchProduct

Characterization of the pleiotropic LysR-type transcription regulator LeuO of Escherichia coli

2019

AbstractLeuO is a pleiotropic LysR-type transcriptional regulator (LTTR) and co-regulator of the abundant nucleoid-associated repressor protein H-NS in Gammaproteobacteria. As other LTTRs, LeuO is a tetramer that is formed by dimerization of the N-terminal DNA-binding domain (DBD) and C-terminal effector-binding domain (EBD). To characterize the Escherichia coli LeuO protein, we screened for LeuO mutants that activate the cas (CRISPR-associated/Cascade) promoter more effectively than wild-type LeuO. This yielded nine mutants carrying amino acid substitutions in the dimerization interface of the regulatory EBD, as shown by solving the EBD’s crystal structure. Superimposing of the crystal str…

Models MolecularProtein domainMutantRepressorPlasma protein bindingBiologymedicine.disease_cause03 medical and health sciencesProtein DomainsTranscription (biology)GeneticsConsensus sequencemedicinePromoter Regions GeneticEscherichia coli030304 developmental biologyGenetics0303 health sciences030306 microbiologyEscherichia coli ProteinsGene regulation Chromatin and EpigeneticsGenetic PleiotropyDNAGene Expression Regulation BacterialDNA-Binding ProteinsMutationNucleic Acid ConformationProtein MultimerizationDeoxyribonuclease IProtein BindingTranscription FactorsNucleic Acids Research
researchProduct